# FDA Inspection 1243197 - Xytex Laboratories - June 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/xytex-laboratories/0fe532d8-aad9-4151-b7e1-ccf681ec07ea
Source feed: FDA_Inspections

> FDA Inspection 1243197 for Xytex Laboratories on June 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243197
- Company Name: Xytex Laboratories
- Inspection Date: 2024-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1176624 - 2022-07-26](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/966c6986-9497-4ed0-80be-da10db457c9d)
- [FDA Inspection 1176624 - 2022-07-26](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/cf36f289-f666-4c01-873c-4d71674fe463)
- [FDA Inspection 1176624 - 2022-07-26](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/92637496-68ab-46f3-8562-ca491057342c)

Company: https://www.keypedia.com/companies/xytex-laboratories/1134cc51-2864-43af-926f-6a4eac4e5b14

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d